MGC Pharmaceuticals Ltd progresses clinical trial planning for CimetrA, CannEpil
All three trials are well funded, following the successful £6.5 million IPO fundraising and listing on the London…
Read More...
Read More...
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.
We respect your privacy and take protecting it seriously
Recover your password.
A password will be e-mailed to you.